Egf Theramed Health Stock Probability of Future Pink Sheet Price Finishing Over 0.22

EVAHF Stock  USD 0.22  0.04  22.22%   
EGF Theramed's future price is the expected price of EGF Theramed instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of EGF Theramed Health performance during a given time horizon utilizing its historical volatility. Check out EGF Theramed Backtesting, EGF Theramed Valuation, EGF Theramed Correlation, EGF Theramed Hype Analysis, EGF Theramed Volatility, EGF Theramed History as well as EGF Theramed Performance.
  
Please specify EGF Theramed's target price for which you would like EGF Theramed odds to be computed.

EGF Theramed Target Price Odds to finish over 0.22

The tendency of EGF Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.22 90 days 0.22 
about 1.12
Based on a normal probability distribution, the odds of EGF Theramed to move above the current price in 90 days from now is about 1.12 (This EGF Theramed Health probability density function shows the probability of EGF Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 1.8 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, EGF Theramed will likely underperform. In addition to that EGF Theramed Health has an alpha of 10.6087, implying that it can generate a 10.61 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   EGF Theramed Price Density   
       Price  

Predictive Modules for EGF Theramed

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as EGF Theramed Health. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.010.2261.22
Details
Intrinsic
Valuation
LowRealHigh
0.010.1761.17
Details
Naive
Forecast
LowNextHigh
00.2582.23
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.070.140.22
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as EGF Theramed. Your research has to be compared to or analyzed against EGF Theramed's peers to derive any actionable benefits. When done correctly, EGF Theramed's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in EGF Theramed Health.

EGF Theramed Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. EGF Theramed is not an exception. The market had few large corrections towards the EGF Theramed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold EGF Theramed Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of EGF Theramed within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
10.61
β
Beta against Dow Jones1.80
σ
Overall volatility
0.06
Ir
Information ratio 0.13

EGF Theramed Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of EGF Theramed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for EGF Theramed Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
EGF Theramed Health is way too risky over 90 days horizon
EGF Theramed Health has some characteristics of a very speculative penny stock
EGF Theramed Health appears to be risky and price may revert if volatility continues
EGF Theramed Health has high likelihood to experience some financial distress in the next 2 years
EGF Theramed Health has accumulated 1.23 M in total debt with debt to equity ratio (D/E) of 6.69, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. EGF Theramed Health has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist EGF Theramed until it has trouble settling it off, either with new capital or with free cash flow. So, EGF Theramed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like EGF Theramed Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for EGF to invest in growth at high rates of return. When we think about EGF Theramed's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (1.35 M) with loss before overhead, payroll, taxes, and interest of (105.22 K).
EGF Theramed Health has accumulated about 51.98 K in cash with (993.42 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.

EGF Theramed Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of EGF Pink Sheet often depends not only on the future outlook of the current and potential EGF Theramed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. EGF Theramed's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.2 M

EGF Theramed Technical Analysis

EGF Theramed's future price can be derived by breaking down and analyzing its technical indicators over time. EGF Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of EGF Theramed Health. In general, you should focus on analyzing EGF Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

EGF Theramed Predictive Forecast Models

EGF Theramed's time-series forecasting models is one of many EGF Theramed's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary EGF Theramed's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about EGF Theramed Health

Checking the ongoing alerts about EGF Theramed for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for EGF Theramed Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
EGF Theramed Health is way too risky over 90 days horizon
EGF Theramed Health has some characteristics of a very speculative penny stock
EGF Theramed Health appears to be risky and price may revert if volatility continues
EGF Theramed Health has high likelihood to experience some financial distress in the next 2 years
EGF Theramed Health has accumulated 1.23 M in total debt with debt to equity ratio (D/E) of 6.69, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. EGF Theramed Health has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist EGF Theramed until it has trouble settling it off, either with new capital or with free cash flow. So, EGF Theramed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like EGF Theramed Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for EGF to invest in growth at high rates of return. When we think about EGF Theramed's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (1.35 M) with loss before overhead, payroll, taxes, and interest of (105.22 K).
EGF Theramed Health has accumulated about 51.98 K in cash with (993.42 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.

Other Information on Investing in EGF Pink Sheet

EGF Theramed financial ratios help investors to determine whether EGF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EGF with respect to the benefits of owning EGF Theramed security.